Insights

Dr. Raj Chovatiya, MD, PhD, reviews recent FDA approval and how addition of new treatments can improve management of vitiligo going forward.

Dr. Raj Chovatiya, MD, PhD, discusses recently approved treatments in atopic dermatitis and how these new additions could be used for newly diagnosed and previously treated patients.

Dr Nehad Soloman explores the advent of new and emerging therapies as well as advances in precision medicine for the management of rheumatology.

Paul Doghramji, MD, FAAFP, provides insight on the use of current treatment modalities for insomnia and the management of sleep disorders in primary care clinics.

Elaine M. Apperson, MD, provides key insights on the screening, diagnosis, and management of type 1 diabetes in patients.

An expert in diabetes care and education discusses considerations in the management of hypoglycemia and diabetes in school aged children.

Dr Peter Kaiser, an ophthalmologist, provides an overview of biosimilars, the regulatory pathway for their approval, and how biosimilars can aid in providing quality care to patients. Dr. Kaiser shares data with ranibizumab biosimilars in ophthalmology and discusses key differences between biosimilar and reference product studies.

Experts in gastroenterology discuss recent updates in the management of ulcerative colitis, highlighting their respective approaches to treatment.

An expert in emergency medicine reviews recent publications examining the efficacy and cost of prescription treatments in the management of opioid induced constipation.

Jerry Bagel, MD, MS, discusses the management of moderate-to-severe plaque psoriasis with a focus on newer agents currently in the drug approval pipeline.

An expert dermatologist provides insight on approaching the optimal treatment and management of vitiligo.

Experts in pulmonology provide insight on the diagnosis and optimal management of idiopathic pulmonary fibrosis (IPF).

Theresa R. Cerulli, MD, discusses current therapy options for the management of attention deficit hyperactivity disorders in the pediatric population.

Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger, DO, MSPH; and John J. Strouse, MD, PhD, explore current therapy options for the management of sickle cell disease and discuss the impact of anemia and hemolysis.

A key opinion leader in neurology, Arun S. Varadhachary, MD, PhD, reviews the case of a 28-year-old with spinal muscular atrophy and considers the role of nusinersen for patients with later-onset SMA.

Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.

Drs Marc P. Bonaca and Manesh R. Patel discuss the role of antiplatelet and anticoagulating agents in the treatment of patients with concurrent type 2 diabetes as per the 2021 ADA Standards of Medical Care in Diabetes.

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review currently available treatment options for the management of opioid-induced constipation.

Michael R. DeBaun, MD, MPH, reviews the use of recent FDA-approved therapies along with the conventional treatment options for the management of sickle cell disease.

Recommendations for appropriate selection and use of anti-VEGF therapy for age-related macular degeneration to reduce treatment burden.

Adam Friedman, MD, FAAD provides insight into how and why insurance companies implement non-medical therapeutic switching and what healthcare providers can do to mitigate its impact on patient care.

Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, discuss current and emerging therapies for the management of attention deficit hyperactivity disorders (ADHD).

The HCPLive Insights series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.

Henry Nasrallah, MD, provides insight on the optimal management of schizophrenia including the use of LAIs.

Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, provide insight on the management of atopic dermatitis and the importance of a multidisciplinary approach to care.